Rchr
J-GLOBAL ID：202101004195910323   Update date: Oct. 17, 2024

Ishiguro Chieko

イシグロ チエコ | Ishiguro Chieko
Affiliation and department：
National Center for Global Health and Medicine Section of Clinical Epidemiology, Department of Data Science, Center for Clinical Sciences

About National Center for Global Health and Medicine Section of Clinical Epidemiology, Department of Data Science, Center for Clinical Sciences


Job title： Section Chief
Research field  (4)： Hygiene and public health (non-laboratory) ,  Clinical pharmacy ,  Pharmacology ,  Statistical science
Research keywords  (5)： pharmacoepidemiology ,  clinical epidemiology ,  medical informatics ,  regulatory science ,  biostatistics
Research theme for competitive and other funds  (12)：
  • 2024 - 2027 リアルワールドデータ駆動型ドラッグ・リポジショニング創薬の基盤開発
  • 2024 - 2027 妊娠期から学童期を紡ぐ保健・医療統合データベース基盤開発とエビデンス創出
  • 2024 - 2027 自治体基盤データベースを活用したワクチンの有効性・安全性・経済性のエビデンス創出研究
  • 2024 - 2027 大規模データベースを活用した承認後ワクチンの安全性評価手法に関する疫学・生物統計学的検討
  • 2023 - 2025 Algorithm development for identifying patients with COVID-19 from claims data
Show all
Papers (53)：
  • Wataru Mimura, Chieko Ishiguro, Megumi Maeda, Fumiko Murata, Haruhisa Fukuda. Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS study. Human vaccines & immunotherapeutics. 2024. 20. 1. 2350091-2350091
  • Taku Chikamochi, Chieko Ishiguro, Wataru Mimura, Megumi Maeda, Fukumiko Murata, Haruhisa Fukuda. Validation Study of the Claims-Based Algorithm Using the International Classification of Diseases Codes to Identify Patients With Coronavirus Disease in Japan From 2020 to 2022: The VENUS Study. Pharmacoepidemiology and Drug Safety. 2024
  • Yusuke Okada, Kazuhiro Kajiyama, Chieko Ishiguro, Takahiro Nonaka, Tomomi Komaki, Wataru Kuga, Noriyuki Komiyama, Toyotaka Iguchi, Naoya Horiuchi, Yoshiaki Uyama. Risk of neutropenia in psoriasis patients prescribed anti-IL-23 antibody in comparison with anti-IL-17 antibody or adalimumab based on real-world data from the MID-NET ® in Japan. Journal of Dermatological Treatment. 2024. 35. 1
  • Validity of Vaccination Information in the COVID-19 Surveillance System in Japan: Implications for Developing Efficient and Highly Valid Data Collection Systems in Future Pandemics. GHM Open. 2024
  • Tomoaki Hasegawa, Maki Komamine, Chieko Ishiguro, Haruka Motomura, Kazuhiro Kajiyama, Takahiro Nonaka, Yuki Nakazato, Ryota Kimura, Harumi Maniwa, Toyotaka Iguchi, et al. Increased risk of hypocalcemia with decreased kidney function in patients prescribed bisphosphonates based on real-world data from the MID-NET® in Japan: a new-user cohort study. BMC nephrology. 2024. 25. 1. 134-134
ｍore...
MISC (12)：
  • 石黒智恵子. ワクチンup to date: 新型コロナウイルスワクチンの小児における安全性と承認後ワクチンの安全性監視. 小児内科. 2023. 55. 9. 1510-1515
  • Establishment and use of a database for the evaluation of effectiveness and safety of post-approval vaccines: the VENUS Study. PMDR. 2022. 53. 6. 507-510
  • 石黒 智恵子. 【最近の疫学】リアルワールドデータを活用した承認後ワクチンの安全性・有効性評価. ファルマシア. 2022. 58. 8. 772-776
  • Chieko ISHIGURO, Yoshiaki UYAMA. Japanese Pharmaceutical Regulation's Paradigm Shift to Real-world Data Utilization in Pharmacovigilance. Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku. 2019. 24. 1. 11-18
  • 岩上将夫, 青木事成, 赤沢学, 石黒智恵子, 今井志乃ぶ, 大場延浩, 草間真紀子, 小出大介, 後藤温, 小林典弘, et al. Task Force Report on the Validation of Diagnosis Codes and Other Outcome Definitions in the Japanese Receipt Data. Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku. 2017. 22. supplement. s49-s52
ｍore...
Books (2)：
  • 薬剤疫学の基礎と実践
    ライフサイエンス出版 2021 ISBN:9784897754390
  • これからの薬剤疫学 : リアルワールドデータからエビデンスを創る
    朝倉書店 2021 ISBN:9784254301236
Lectures and oral presentations  (91)：
  • Modrator for Concurrent Contributed Papers: Medication Access / Regulation
    (2024 ACPE Annual Meeting. 12-14 Ougust 2024. Tokyo, Japan 2024)
  • Validation of claims-based algorithms for intussusception in Japan: The CLEAR Study
    (2024 ACPE Annual Meeting. 12-14 Ougust 2024. Tokyo, Japan 2024)
  • Symposium 9: Three approaches to conduct real-world studies across multiple healthcare systems: common research question, common protocol, and common data model
    (2024 ACPE Annual Meeting. 12-14 Ougust 2024. Tokyo, Japan 2024)
  • Symposium 2:Leveraging Electronic Health Records in Japan pharmaceutical industry: current status, issues, futures
    (2024 ACPE Annual Meeting. 12-14 Ougust 2024. Tokyo, Japan 2024)
  • Missing data analysis methods to correct outcome mismeasurement in pharmacoepidemiological studies using electronic medical information: Methodologies and recommendations for future validation studies
    (2024)
ｍore...
Work history (7)：
  • 2021/04 - 現在 National Center for Global Health and Medicine Center for Clinical Sciences, Department of Data Science Section Chief of Clinical Epidemiology
  • - 現在 Tokyo University of Science Faculty of Engineering
  • - 現在 The Institute of Statistical Mathematics
  • 2006/03 - 2021/03 Pharmaceuticals and Medical Devices Agency Office of Medical Informatics and Epidemiology
  • The Institute of Statistical Mathematics
Show all
Committee career (8)：
  • 2024/01 - 現在 日本薬剤疫学会 国際連携委員会
  • 2024/01 - 現在 日本薬剤疫学会 健康・医療情報データベース活用委員会
  • 2024/01 - 現在 16th ACPE & 29th JCPE Joint Conference Local Host Committee
  • 2021/05 - 現在 独立行政法人医薬品医療機器総合機構 専門委員(疫学)
  • 2019/10 - 現在 日本薬剤疫学会 認定・教育委員会 委員
Show all
Awards (4)：
  • 2017/07 - International Society of Pharmacoepidemiology (ISPE) Best reviewer award in 2016 Pharmacoepidemiology and Drug Safety
  • 2016/04 - 医薬品医療機器総合機構 理事長賞
  • 2016/02 - 第3回 藤田利治賞(薬剤疫学部門)
  • 2006/03 - 京都大学大学院医学系研究科社会健康医学系専攻 最優秀賞
Association Membership(s) (5)：
レギュラトリーサイエンス学会 ,  日本疫学会 ,  日本ワクチン学会 ,  International Society for Pharmacoepidemiology (ISPE) ,  日本薬剤疫学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM